drugset / Trial / NCT01215214
Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity Using Metabolomics
Phase 1
Completed
24 enrolled
Seoul National University Hospital
Ministry of Education Science and Technology, Korea · collab
Non-randomizedCrossoverOpen-labelTreatment
Summary
Identification and evaluation of endogenous markers for the assessment of CYP3A activity using metabolomics.
Timeline
- Start
- 2010-10
- Primary completion
- 2010-11
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midazolam | Small molecule | 3 mg | Intravenous |
Indications
No indication recorded.